Zymeworks ZYME Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $244.28M+494% | $41.16M-36.5% | $64.83M-34.0% | $98.25M+28.9% | $76.2M+15.3% | ||
| $4.67M+0.8% | $4.64M-84.2% | $29.35M+1,016% | $2.63M-89.3% | $24.59M-55.9% | ||
| $385.68M+55.0% | $248.77M-14.7% | $291.71M-1.5% | $296.13M-3.4% | $306.47M+2.0% | ||
| $14.85M-4.2% | $15.5M-2.0% | $15.82M-3.0% | $16.31M-2.2% | $16.69M-5.5% | ||
| $12.02M0.0% | $12.02M0.0% | $12.02M0.0% | $12.02M0.0% | $12.02M0.0% | ||
| $1.17M-13.0% | $1.35M-3.4% | $1.4M-31.7% | $2.05M-39.2% | $3.36M-26.5% | ||
| $39.12M-6.4% | $41.79M-11.9% | $47.43M-8.8% | $52M-7.7% | $56.32M-42.8% | ||
| $478.22M+38.0% | $346.53M-12.8% | $397.27M-2.7% | $408.39M-4.0% | $425.52M-8.1% | ||
| $30.23M-16.8% | $36.35M+2,685% | $1.31M+3,978% | $32K-99.4% | $5.22M+33.8% | ||
| $2.08M-14.1% | $2.42M-24.4% | $3.2M-16.1% | $3.81M-83.8% | $23.5M-8.2% | ||
| $35.65M-15.8% | $42.32M+0.7% | $42.04M+9.2% | $38.5M-40.9% | $65.1M-26.3% | ||
| $314.63M+303% | $78.03M+1.1% | $77.21M+4.5% | $73.88M-26.5% | $100.56M-19.1% | ||
| 900M0.0% | 900M0.0% | 900M0.0% | 900M0.0% | 900M-11.4% | ||
| -$1.07B-12.7% | -$953.16M-7.5% | -$886.47M-4.2% | -$850.65M+0.3% | -$852.97M-2.7% | ||
| $163.59M-39.1% | $268.5M-16.1% | $320.06M-4.3% | $334.51M+2.9% | $324.97M-4.1% | ||
| $478.22M+38.0% | $346.53M-12.8% | $397.27M-2.7% | $408.39M-4.0% | $425.52M-8.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Zymeworks cover its short-term obligations?
- Its current ratio is 10.82 — current assets exceed current liabilities.
- Where does Zymeworks's balance sheet data come from?
- Every line is extracted from Zymeworks's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.